360 related articles for article (PubMed ID: 16939428)
1. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease.
Tack J
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():10-6. PubMed ID: 16939428
[TBL] [Abstract][Full Text] [Related]
2. Review article: role of pepsin and bile in gastro-oesophageal reflux disease.
Tack J
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():48-54. PubMed ID: 16042659
[TBL] [Abstract][Full Text] [Related]
3. The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease?
Strugala V; Avis J; Jolliffe IG; Johnstone LM; Dettmar PW
J Pharm Pharmacol; 2009 Aug; 61(8):1021-8. PubMed ID: 19703345
[TBL] [Abstract][Full Text] [Related]
4. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
5. Bile acids and Barrett's oesophagus: a sine qua non or coincidence?
Sital RR; Kusters JG; De Rooij FW; Kuipers EJ; Siersema PD
Scand J Gastroenterol Suppl; 2006; (243):11-7. PubMed ID: 16782617
[TBL] [Abstract][Full Text] [Related]
6. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targets in gastro-oesophageal reflux disease.
Piche T; Galmiche JP
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
[TBL] [Abstract][Full Text] [Related]
8. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
Hirano I
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
[TBL] [Abstract][Full Text] [Related]
9. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces.
Farré R; van Malenstein H; De Vos R; Geboes K; Depoortere I; Vanden Berghe P; Fornari F; Blondeau K; Mertens V; Tack J; Sifrim D
Gut; 2008 Oct; 57(10):1366-74. PubMed ID: 18593808
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
Tack J
Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
[TBL] [Abstract][Full Text] [Related]
11. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls.
Fiorucci S; Distrutti E; Di Matteo F; Brunori P; Santucci L; Mallozzi E; Bigazzi U; Morelli A
Am J Gastroenterol; 1995 Feb; 90(2):270-6. PubMed ID: 7847299
[TBL] [Abstract][Full Text] [Related]
12. Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease.
De Hertogh G; Ectors N; Van Eyken P; Geboes K
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():17-26. PubMed ID: 16939429
[TBL] [Abstract][Full Text] [Related]
13. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
Katz PO
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
[TBL] [Abstract][Full Text] [Related]
14. Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.
Vakil N
Aliment Pharmacol Ther; 2004 May; 19(10):1041-9. PubMed ID: 15142193
[TBL] [Abstract][Full Text] [Related]
15. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
Roman S; Serraj I; Damon H; Mion F
Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
[TBL] [Abstract][Full Text] [Related]
16. Duodenogastro-oesophageal reflux.
Vaezi MF; Richter JE
Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):719-29. PubMed ID: 11003805
[TBL] [Abstract][Full Text] [Related]
17. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.
Vaezi MF
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():40-9. PubMed ID: 16483269
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of gastro-oesophageal reflux disease.
De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
[TBL] [Abstract][Full Text] [Related]
19. Review article: gastro-oesophageal reflux disease as a functional gastrointestinal disorder.
Kahrilas PJ
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():50-5. PubMed ID: 15521855
[TBL] [Abstract][Full Text] [Related]
20. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease.
Nehra D; Howell P; Pye JK; Beynon J
Br J Surg; 1998 Jan; 85(1):134-7. PubMed ID: 9462405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
